Medications for Alcohol Use Disorders in a Primary Care Practice-Based Research Network Implementation Study

National Institute on Alcohol Abuse and Alcoholism recommendations encourage clinicians to consider the use of alcohol medications (ARx), acamprosate, disulfiram, naltrexone, or topiramate, for patients with alcohol use disorders (AUD). These recommendations have not yet been implemented in U.S. pri...

Full description

Saved in:
Bibliographic Details
Published in:Alcoholism treatment quarterly 2014-01, Vol.32 (1), p.58-66
Main Authors: Wessell, Andrea M., Nemeth, Lynne S., Jenkins, Ruth G., Ornstein, Steven M., Miller, Peter M.
Format: Article
Language:English
Subjects:
Alcohol Abuse
alcohol use disorder
Alcoholism
alcoholism therapy
Implementation
Patients
Practice-based research network
primary care
Primary Health Care
Trials
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:National Institute on Alcohol Abuse and Alcoholism recommendations encourage clinicians to consider the use of alcohol medications (ARx), acamprosate, disulfiram, naltrexone, or topiramate, for patients with alcohol use disorders (AUD). These recommendations have not yet been implemented in U.S. primary care practices. This mixed-methods substudy reports overall ARx use and facilitators to ARx use observed during a group-randomized trial in 19 practices. Nine percent of patients with a documented AUD diagnosis (n = 149 patients) received an ARx prescription. Facilitators to ARx use were exposure to evidence, limited referral options, receptive patients, successful outcomes, low cost of oral naltrexone, and familiarity with topiramate. Findings may affect the development of future primary care implementation programs.
ISSN:0734-7324
1544-4538
DOI:10.1080/07347324.2014.856224